Clinical trial
Using Medical-detection Dogs to Identify People With SARS-CoV-: Phase I: Proof-of-concept Studies
NCT04509713 is registered in ClinicalTrials.gov with ARCTEC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Medical-detection Dogs to Identify People With SARS-CoV-: Phase I: Proof-of-concept Studies
- Lead sponsor
- ARCTEC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 2, 2020
- Completion date
- October 31, 2020
- Enrollment
- 16,250 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid19